CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
April 20, 2022 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the first patient has been safely treated in its recently...
CLS Americas and URN Announce Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
March 29, 2022 08:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, March 29, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the company’s TRANBERG® Thermal Therapy System will be used...
Clinical Laserthermia Systems AB Promotes Michael Magnani to President of its U.S. Subsidiary, CLS Americas Inc
January 03, 2022 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS AB) (Stockholm: CLS B), developer of high precision, image-guided focal laser ablation (FLA) systems,...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
November 18, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced the...
CLS Again Releases TRANBERG® Sterile Disposable Products into the US Market
November 18, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced the...
CLS Americas Debuts MRI-US Fusion-Guided Focal Laser Ablation System at 97th Annual WSAUA Conference
November 02, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
Company Goal to Enable Minimally-Invasive, Focal Therapy Procedure to be Performed in an Office Setting or Clinic under Local Anesthetic INDIAN WELLS, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) --...
CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
October 25, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...
CLS Americas Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
October 25, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...
CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
October 15, 2021 04:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
CLS Exhibits High Precision, Image-Guided Focal Laser Ablation System at the 73rd Congress of the German Society for Urology Conference
September 14, 2021 03:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
STUTTGART, Germany, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...